Docoh
Loading...

20 results

Filter options loading...
Top filers
Top filing types
Recent filing years
8-K
EX-1.1
PCSA Processa Pharmaceuticals Inc
20 Aug 21
Entry into a Material Definitive Agreement
4:30pm
to qualifications and exceptions contained therein relating to materiality or Material Adverse Change, are true and correct on and as of the date
S-3
EX-5.1
PCSA Processa Pharmaceuticals Inc
30 Jun 21
Shelf registration
4:02pm
) the effect of general principles of equity, including without limitation concepts of materiality, reasonableness, good faith and fair dealing (regardless
10-K
2020 FY
PCSA Processa Pharmaceuticals Inc
24 Mar 21
Annual report
8:00pm
identified the analysis for potential impairment of this intangible asset as a critical audit matter due to the materiality of the asset. To test … to the materiality of the transactions as well as the added complexity involving the issuance of common stock in conjunction with acquiring the licenses. To test
8-K
EX-10.1
PCSA Processa Pharmaceuticals Inc
18 Feb 21
Processa Pharmaceuticals Announces $10.2 Million Strategic Financing
10:08am
representations or warranties are qualified by materiality or Material Adverse Effect, in all respects) on the Closing Date of the representations and warranties … or warranties are qualified by materiality or Material Adverse Effect, in all respects) when made and on the Closing Date of the representations
8-K
PCSA Processa Pharmaceuticals Inc
18 Feb 21
Processa Pharmaceuticals Announces $10.2 Million Strategic Financing
10:08am
between the parties to the Purchase Agreement and not as statements of fact, and (ii) may apply standards of materiality in a way that is different from
S-1/A
6y11l77lfhk3m p0ut
30 Sep 20
IPO registration (amended)
4:06pm
S-1/A
0jvne
16 Sep 20
IPO registration (amended)
8:00pm
S-1/A
EX-2.1
ksius904ci4 hzzz
16 Sep 20
IPO registration (amended)
8:00pm
S-1/A
EX-10.11
gln1az
16 Sep 20
IPO registration (amended)
8:00pm
S-1/A
EX-10.12
ooiajnsky 59tbu
16 Sep 20
IPO registration (amended)
8:00pm
8-K
EX-10.1
952dxsqxknpz3 6qwyi
20 Aug 20
Entry into a Material Definitive Agreement
9:30am
8-K
EX-10.2
20vitrfw0x y0
20 Aug 20
Entry into a Material Definitive Agreement
9:30am
S-1/A
kti8yqdw
17 Jul 20
IPO registration (amended)
5:25pm
S-1
itub7
13 Dec 19
IPO registration
5:32pm
S-1/A
d18m wok3ol6uv6
30 Oct 18
IPO registration (amended)
4:19pm
S-1/A
cji04n
9 Oct 18
IPO registration (amended)
5:32pm
S-1/A
s74h3vam3fpo0zmhvk3z
13 Sep 18
IPO registration (amended)
8:00pm
S-1
4wktqo
29 Jul 18
IPO registration
8:00pm
8-K
EX-2.1
zaooo zln1f3q
4 Oct 17
Heatwurx, Inc Announces Execution of Definitive Asset Purchase Agreement with Promet Therapeutics, LLC
8:00pm
8-K
EX-99.2
yl2dx6j clfnhquoa
8 Jan 14
Entry into a Material Definitive Agreement
7:00pm
  • 1